- Report
- October 2024
- 181 Pages
Global
From €3360EUR$3,545USD£2,807GBP
€3733EUR$3,939USD£3,119GBP
- Report
- January 2025
- 150 Pages
Global
From €5640EUR$5,950USD£4,711GBP
- Report
- April 2023
- 115 Pages
Global
From €4502EUR$4,750USD£3,761GBP
- Report
- September 2022
- 300 Pages
Global
From €3640EUR$3,840USD£3,041GBP
Bovine Mastitis Drug is a type of animal pharmaceutical used to treat mastitis, an inflammation of the mammary glands in cows. It is a common and costly disease in dairy herds, and can lead to decreased milk production, increased culling, and increased veterinary costs. Bovine Mastitis Drugs are typically administered intramammary, and can be either systemic or topical. Systemic drugs are absorbed into the bloodstream and distributed throughout the body, while topical drugs are applied directly to the affected area. Common active ingredients in Bovine Mastitis Drugs include antibiotics, anti-inflammatory agents, and antifungals.
Some companies in the Bovine Mastitis Drug market include Elanco, Merck Animal Health, Zoetis, Boehringer Ingelheim, and Bayer Animal Health. Show Less Read more